Blood group-specific apheresis in combination with daratumumab as a rescue therapy of acute antibody-mediated rejection in a case of ABO- and human leukocyte antigen-incompatible kidney transplantation

We report a case of antibody-mediated rejection treated with the human CD38 monoclonal antibody daratumumab in a 58-year-old female patient with end-stage kidney disease due to autosomal dominant polycystic kidney disease who received an ABO- and human leukocyte antigen antibody-incompatible living...

Descripción completa

Detalles Bibliográficos
Autores principales: Süsal, Can C, Kraft, Leonie, Ender, Andrea, Süsal, Caner, Schwenger, Amelie, Amann, Kerstin, Böhmig, Georg A, Schwenger, Vedat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631334/
https://www.ncbi.nlm.nih.gov/pubmed/38022864
http://dx.doi.org/10.1177/2050313X231211050

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10631334/
https://www.ncbi.nlm.nih.gov/pubmed/38022864
http://dx.doi.org/10.1177/2050313X231211050

Ejemplares similares